ESC Premium Access

Real-world clinical data of atrial fibrillation patients treated with direct oral anticoagulants in combination with or without antiplatelet therapy

Congress Session

About the speaker

Doctor Ryohei Amiya

Osaka University, Osaka (Japan)
0 follower

5 more presentations in this session

Characterization of major and clinically relevant non-major bleeding in the APEX trial

Speaker: Miss M. Yee (Boston, US)

Thumbnail

Increased major bleeding risk with use of topical miconazole agents among users of oral anticoagulation: A population-level safety study

Speaker: Doctor M. Lamberts (Copenhagen, DK)

Thumbnail

Differences between hospitalised vs. outpatient management amongst european patients with atrial fibrillation: the EORP-AF general long-term registry

Speaker: Doctor M. Proietti (Milan, IT)

Thumbnail

Comparison of P2Y12 inhibitors in atrial fibrillation patients treated by dual-antiplatelet therapy without oral anticoagulant after acute myocardial infarction with percutaneous coronary intervention

Speaker: Professor H. Jeong (Gwangju, KR)

Thumbnail

Oral anticoagulants in patients with atrial fibrillation and non-mechanical heart valve disease

Speaker: Mr J. Strange (Hellerup, DK)

Thumbnail

Access the full session

Oral anticoagulants : news from large trials and registries

Speakers: Doctor R. Amiya, Miss M. Yee, Doctor M. Lamberts, Doctor M. Proietti, Professor H. Jeong...
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk